From October 19 to 21, 2025, the "Science Journal High-Quality Development Seminar and the 12th Anniversary of KeAi" was successfully held at the Portman Seven Stars Bay Hotel in Xiamen. Organized by Beijing KeAi Senlan Cultural Communication Co., Ltd., the conference gathered experts and scholars from the field of journal publishing both domestically and internationally to discuss strategies for high-quality development in scientific publishing.
The "Current Pharmaceutical Analysis" (CPA) journal was honored with the "Great Progress Award" for its significant advancements in journal development and academic dissemination. The journal's impact factor has doubled to 1.5, reflecting the substantial increase in its academic influence and recognition.
Conference Themes Included:
-
Analysis of the development trends and cutting-edge insights of scientific journals.
-
Strategies for promoting the international development of journals.
-
Sharing key points for institution-based journal publishing.
CPA's Achievements:
The CPA journal's impact factor has doubled to 1.5, with a CiteScore提升至1.7 (translated as "rising to 1.7"), indicating a steady increase in academic influence and citation rates within its field. This award is a testament to the journal's quality and academic value, acknowledging the efforts of the team to enhance the journal's quality and international presence.
The CPA journal has been committed to providing a high-quality academic exchange platform for global pharmaceutical researchers. It covers various aspects of pharmaceutical analysis, including drug development, metabolism, and quality control. The journal ensures the scientific rigor and innovation of each article through a rigorous peer-review process and professional editorial procedures.
The progress of the CPA journal is not only reflected in quantitative indicators but also in its continuous pursuit of high-quality research outcomes and the optimization of the academic exchange platform. The journal is dedicated to publishing innovative and cutting-edge research findings, offering a high-quality academic exchange platform for pharmaceutical researchers worldwide.
The successful convening of this conference has pointed out the direction for the future development of China's scientific journals and laid a solid foundation for enhancing their international influence and competitiveness. It is anticipated that through continuous efforts and innovation, China's scientific journals will play a greater role on the international stage, contributing more Chinese wisdom to global scientific innovation.
Journal
Current Pharmaceutical Analysis